tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
ELVN
Enliven Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Enliven Therapeutics (ELVN) Stock News & Sentiment

Compare
285 Followers
Buy Rating for Enliven Therapeutics Driven by Promising Market Dynamics and Growth Prospects
Premium
Ratings
Buy Rating for Enliven Therapeutics Driven by Promising Market Dynamics and Growth Prospects
11d ago
ELVN
Enliven Therapeutics: Promising Developments and Strategic Plans Justify Buy Rating
Premium
Ratings
Enliven Therapeutics: Promising Developments and Strategic Plans Justify Buy Rating
14d ago
ELVN
Enliven Therapeutics: Promising Pipeline and Financial Stability Drive Buy Rating
Premium
Ratings
Enliven Therapeutics: Promising Pipeline and Financial Stability Drive Buy Rating
19d ago
ELVN
Enliven Therapeutics: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
Premium
Ratings
Enliven Therapeutics: Promising Clinical Progress and Strong Financial Position Justify Buy Rating
19d ago
ELVN
Enliven Therapeutics Reports 2024 Financial Results
Premium
Company Announcements
Enliven Therapeutics Reports 2024 Financial Results
20d ago
ELVN
Enliven Therapeutics: Promising Innovations in Tyrosine Kinase Inhibitors and Strategic Growth Plans Justify Buy Rating
Premium
Ratings
Enliven Therapeutics: Promising Innovations in Tyrosine Kinase Inhibitors and Strategic Growth Plans Justify Buy Rating
2M ago
ELVN
Strong Buy Recommendation for Enliven Therapeutics Due to ELVN-001’s High Selectivity and Promising Clinical Data
Premium
Ratings
Strong Buy Recommendation for Enliven Therapeutics Due to ELVN-001’s High Selectivity and Promising Clinical Data
2M ago
ELVN
More ELVN News >

ELVN News on the Web

Decoding Enliven Therapeutics Inc (ELVN): A Strategic SWOT Insight
GuruFocus News
Neutral
Enliven Therapeutics Is In A Good Position To Deliver On Growth Plans
Yahoo Finance
Neutral
COMMODORE CAPITAL LP Acquires 600,000 Shares in Neurogene Inc
GuruFocus News
Neutral
Enliven Therapeutics’ ELVN-001: Navigating Competitive Challenges and Opportunities in the CML Market
TipRanks News
Bullish
Enliven Therapeutics: Strategic Positioning and Promising Developments Justify Buy Rating
TipRanks News
Bullish
Enliven Therapeutics: Promising Clinical Developments and Robust Financial Position Justify Buy Rating
TipRanks News
Bullish
Enliven Therapeutics, Inc. (ELVN) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks
Bullish
Enliven Therapeutics’ ELVN-001 shows promise in Phase I CML trial
Clinical Trials Arena
Bullish

News Score - Last 7 Days

Neutral
ELVN
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ELVN’s Media Buzz Sentiment?
Currently, no data Available
What is ELVN’s weekly average amount of articles?
Currently, no data Available
What is ELVN’s News Sentiment?
59% of articles about ELVN were positive this week, compared to its sector average of 57%.
    Healthcare Stocks that are Trending in the News
    CORTCorcept Therapeutics
    INMBInmune Bio
    PIIIP3 Health Partners
    HAWPFHaw Par
    OGNOrganon
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing